Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPK1 | P28482 | 3/20 | 0.48 |
| ▸ | HTT | P42858 | 1/20 | 0.48 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.39 |
| ▸ | POLB | P06746 | 2/20 | 0.39 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.39 |
| ▸ | MEN1 | O00255 | 1/20 | 0.39 |
| ▸ | HPGD | P15428 | 1/20 | 0.39 |
| ▸ | DUSP3 | P51452 | 1/20 | 0.39 |
| ▸ | PTPN5 | P54829 | 1/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.39 |
| ▸ | PTPN11 | Q06124 | 1/20 | 0.39 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.39 |
| ▸ | LMNA | P02545 | 1/20 | 0.38 |
| ▸ | TSHR | P16473 | 1/20 | 0.38 |
| ▸ | PIK3CD | O00329 | 1/20 | 0.36 |
| ▸ | PIK3CA | P42336 | 1/20 | 0.36 |
| ▸ | PIK3CB | P42338 | 1/20 | 0.36 |
| ▸ | PIK3CG | P48736 | 1/20 | 0.36 |
| ▸ | NR1H2 | P55055 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL26345305 | 0.92 | MAPK1 (0.44) | MAPK1HTTSMN1; SMN2ALDH1A1POLB | |
| SCHEMBL21392706 | 0.90 | MAPK1 (0.47) | MAPK1HTTSMN1; SMN2ALDH1A1POLB | |
| SCHEMBL26345566 | 0.89 | MAPK1 (0.46) | MAPK1HTTSMN1; SMN2ALDH1A1POLB | |
| SCHEMBL21392432 | 0.89 | POLB (0.41) | MAPK1HTTSMN1; SMN2ALDH1A1POLB | |
| SCHEMBL21392566 | 0.88 | ESR1 (0.50) | MAPK1HTTSMN1; SMN2ALDH1A1MEN1 | |
| SCHEMBL21392456 | 0.88 | MAPK1 (0.47) | MAPK1HTTSMN1; SMN2ALDH1A1POLB | |
| SCHEMBL26345603 | 0.88 | POLB (0.41) | MAPK1HTTSMN1; SMN2ALDH1A1POLB | |
| SCHEMBL26345263 | 0.87 | ESR1 (0.45) | MAPK1HTTSMN1; SMN2ALDH1A1MEN1 | |
| SCHEMBL26345662 | 0.86 | MAPK1 (0.43) | MAPK1HTTSMN1; SMN2ALDH1A1POLB | |
| SCHEMBL26370083 | 0.85 | ESR2 (0.37) | MAPK1HTTSMN1; SMN2ALDH1A1POLB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11877509-B2 | Organic light-emitting element | LG CHEM, LTD. | 2024-01-16 | — | — | US | disclosed |
| US-11877509-B2 | Organic light-emitting element | LG CHEM, LTD. | 2024-01-16 | — | — | US | disclosed |
| US-20230309380-A1 | COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENCE DEVICE, ORGANIC ELECTROLUMINESCENCE DEVICE, AND ELECTRONIC APPARATUS | IDEMITSU KOSAN CO.,LTD. (JP) | 2023-09-28 | — | — | US | disclosed |
| US-20190296238-A1 | Organic Light-emitting Element | LG CHEM, LTD. (KR) | 2019-09-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190296238-A1 | Organic Light-emitting Element | CRY1, CRY2, NR2E3 | MAPK1 4606/4885HTT 2428/4885SMN1; SMN2 2267/4885 |
| US-20230309380-A1 | COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENCE DEVICE, ORGANIC ELECTROLUMINESCENCE DEVICE, AND ELECTRONIC APPARATUS | PIEZO1, OR10J3, TMEM109 | MAPK1 675/4885HTT 2655/4885SMN1; SMN2 4064/4885 |
| US-11877509-B2 | Organic light-emitting element | CRY1, CRY2, NR2E3 | MAPK1 4606/4885HTT 2428/4885SMN1; SMN2 2267/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.